Sustained Transmission of Neisseria gonorrhoeae Strains with High-Level Azithromycin Resistance (MIC ≥ 256 μg/mL) in Argentina, 2018 to 2022.


Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
17 08 2023
Historique:
medline: 21 8 2023
pubmed: 20 6 2023
entrez: 20 6 2023
Statut: ppublish

Résumé

Azithromycin combined with ceftriaxone is the recommended dual therapy for uncomplicated gonorrhea in many countries. Nevertheless, the increasing prevalence of azithromycin resistance compromises the effectiveness of this treatment strategy. From 2018 to 2022, we collected 13 gonococcal isolates with high-level azithromycin resistance (MIC ≥ 256 μg/mL) across Argentina. Whole-genome sequencing revealed that these isolates were mainly represented by the internationally spreading Neisseria gonorrhoeae multi-antigen sequence typing (NG-MAST) genogroup G12302, containing the 23S rRNA A2059G mutation (in all four alleles) together with mosaic

Identifiants

pubmed: 37338369
doi: 10.1128/spectrum.00970-23
pmc: PMC10433793
doi:

Substances chimiques

Azithromycin 83905-01-5
Anti-Bacterial Agents 0
Ceftriaxone 75J73V1629
Antigens, Bacterial 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0097023

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Lancet Microbe. 2020 Aug;1(4):e154-e164
pubmed: 33005903
J Antimicrob Chemother. 2021 Mar 12;76(4):940-944
pubmed: 33411920
Int J STD AIDS. 2020 Oct 29;:956462420949126
pubmed: 33121366
Int J STD AIDS. 2020 Jan;31(1):4-15
pubmed: 31870237
Microb Genom. 2020 Apr;6(4):
pubmed: 32213251
J Antimicrob Chemother. 2021 Mar 12;76(4):930-935
pubmed: 33367806
Lancet Infect Dis. 2016 Nov;16(11):1295-1303
pubmed: 27427203
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
Lancet Microbe. 2021 Nov;2(11):e627-e636
pubmed: 35544082
Lancet Microbe. 2022 Jun;3(6):e452-e463
pubmed: 35659907
Bioinformatics. 2016 Apr 1;32(7):1009-15
pubmed: 26589280
Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0168821
pubmed: 34978884
Clin Infect Dis. 2021 Sep 7;73(5):808-815
pubmed: 34492693
J Antimicrob Chemother. 2019 Jun 1;74(6):1551-1559
pubmed: 30820563
J Infect Dis. 2020 Nov 9;222(11):1816-1825
pubmed: 32163580
Emerg Infect Dis. 2021;27(9):2369-2378
pubmed: 34424175
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187
pubmed: 34292926
Nucleic Acids Res. 2021 Jul 2;49(W1):W293-W296
pubmed: 33885785
J Antimicrob Chemother. 2005 Nov;56(5):856-60
pubmed: 16162665
mBio. 2018 Aug 7;9(4):
pubmed: 30087172

Auteurs

Ricardo Ariel Gianecini (RA)

World Health Organization Collaborating Centre for Antimicrobial Resistance, National Reference Laboratory of Sexually Transmitted Diseases (STD), National Institute of Infectious Diseases - ANLIS "Dr. Carlos G. Malbrán", Ciudad Autónoma de Buenos Aires, Argentina.

Tomas Poklepovich (T)

National Center of Genomics and Bioinformatics - ANLIS "Dr. Carlos G. Malbrán", Ciudad Autónoma de Buenos Aires, Argentina.

Daniel Golparian (D)

World Health Organization Collaborating Centre for Gonorrhoea and Other STIs, Örebro University, Örebro, Sweden.

Noelia Cuenca (N)

World Health Organization Collaborating Centre for Antimicrobial Resistance, National Reference Laboratory of Sexually Transmitted Diseases (STD), National Institute of Infectious Diseases - ANLIS "Dr. Carlos G. Malbrán", Ciudad Autónoma de Buenos Aires, Argentina.

Laura Scocozza (L)

Laboratorio Bacteriología, Hospital Fernández, Ciudad Autónoma de Buenos Aires, Argentina.

Silvina Bergese (S)

Laboratorio Bacteriología, Hospital Alemán, Ciudad Autónoma de Buenos Aires, Argentina.

Liliana Fernández Canigia (LF)

Laboratorio Bacteriología, Hospital Alemán, Ciudad Autónoma de Buenos Aires, Argentina.

Viviana Vilches (V)

Laboratorio Microbiología, Hospital Universitario Austral, Buenos Aires, Argentina.

María Julia Lazzarino Elgart (MJ)

Laboratorio Bacteriología, Hospital Rawson, Córdoba, Argentina.

Magnus Unemo (M)

World Health Organization Collaborating Centre for Gonorrhoea and Other STIs, Örebro University, Örebro, Sweden.
Institute for Global Health, University College London, London, United Kingdom.

Josefina Campos (J)

National Center of Genomics and Bioinformatics - ANLIS "Dr. Carlos G. Malbrán", Ciudad Autónoma de Buenos Aires, Argentina.

Patricia Galarza (P)

World Health Organization Collaborating Centre for Antimicrobial Resistance, National Reference Laboratory of Sexually Transmitted Diseases (STD), National Institute of Infectious Diseases - ANLIS "Dr. Carlos G. Malbrán", Ciudad Autónoma de Buenos Aires, Argentina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH